Local Pharmaceutical Manufacturing for Future Sustainability
… Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
AIDS Drug Tender Controversy Raises Serious Questions
Delve into the AIDS Drug Tender Controversy where Motsoaledi points to the DG in the R15.5bn ARV procurement scandal.
Competition Commission Pharma Probe Expands Scope
The Competition Commission has initiated an early-stage investigation into several pharmaceutical manufacturers following a complaint from the national health department. The companies named include Ascendis, Pharma Q and Sonke, all of which supply medicines to the state…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
Lenacapavir HIV Prevention Injection to Reach Too Few
South Africa’s first consignment of lenacapavir, a six-monthly HIV prevention injection for high-risk HIV-negative people, will cover fewer than a quarter of the target population. Deliveries are underway and will continue through April. Rollout will begin immediately after delivery, with an initial two-year implementation plan…. Membership Required You must be a member to access this...
Barrs Pharmaceuticals Secures R92m Hetero Investment
Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
ARV Supply Reassurance After Business Rescue Reports
SA's ARV Supply remains stable after two tender suppliers entered business rescue and contingency plans were put in place.
AIDS Drug Tender: Pressure as Suppliers Enter Business Rescue
The AIDS drug tender reveals challenges in supply continuity due to Avacare subsidiaries entering business rescue.
HIV Drug Tender Facing Legal Challenge from Hetero SA
Hetero SA challenges the HIV drug tender decision in court, claiming exclusion from vital antiretroviral supply contracts.